Results 61 to 70 of about 6,619,911 (229)
Anti-GBM disease and ANCA during dengue infection
Anti-glomerular basement membrane (GBM) disease is a severe inflammatory renal disorder due to pathogenic autoantibodies directed mainly against the α3 chain of type IV collagen.
Contreras, Gabriel N +7 more
core +1 more source
We developed a patient‐derived, functional microfluidic model of the diffuse midline glioma (DMG) blood–brain–tumor barrier (BBTB) comprised of endothelial cells, astrocytes, pericytes, and tumor cells. The system forms perfusable microvasculature, reveals the BBTB retains vascular integrity, identifies DMG‐specific transcriptomic changes distinct from
Kimberly R. Bennett +7 more
wiley +1 more source
Biologically derived and hybrid nonviral nanovectors are examined as distinct but convergent design approaches. Integrating synthetic components with biologically functionalized membranes allows efficient interactions with complex cellular environments.
Clara Baldari +10 more
wiley +1 more source
IgA Vasculitis and Anti-GBM disease: two ends of a spectrum of immune complex vasculitis [PDF]
Two immune complex vasculitides, IgA vasculitis (IgAV) and anti-GBM disease, represent polar extremes with regard to our understanding of disease pathogenesis, standardized management protocols and outcomes.
Salama, A
core +1 more source
Advanced Materials for Biologics Delivery to Brain Tumors
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng +4 more
wiley +1 more source
Renal-Limited Antiglomerular Basement Membrane Disease Related To Alemtuzumab: A Case Report
Rationale: Alemtuzumab is a monoclonal antibody approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). Many autoimmune-mediated adverse events have been associated with alemtuzumab, including renal-limited anti-glomerular basement ...
Amye M. Harrigan +3 more
doaj +1 more source
LF15-0195 prevents the induction and inhibits the progression of rat anti-GBM disease [PDF]
LF15-0195 prevents the induction and inhibits the progression of rat anti-GBM disease.BackgroundLF15-0195 is a novel immunosuppressant that is currently in phase II clinical trials for the treatment of vasculitis.
Wei, Mu +5 more
core +1 more source
Background: Anti-GBM disease is a rare type of severe small vessel vasculitis that can lead to pulmonary haemorrhage and kidney failure. Epidemiologic studies of unselected patients have been challenged due to the low disease incidence and non-relapsing ...
Szpirt, Wladimir +9 more
core +1 more source
In TP53mut GBM cells, reduced P53 function is associated with increased TET1 expression. Genetic or pharmacological inhibition of TET1 correlates with genome fragility, including DNA damage, cellular senescence, telomere shortening, and reactive oxygen species accumulation, which may contribute to increased efficacy of antitumor therapy.
Zhuonan Pu +12 more
wiley +1 more source
A man in his late 20s, a smoker, presented with nephrotic-range proteinuria and mild renal failure. He had no macroscopic hematuria or decreased urine output.
Kaaviya Ramesh +3 more
doaj +1 more source

